ロード中...
Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels
Current treatments for Alzheimer’s disease (AD) attenuate the progression of symptoms and aim to improve the patient’s quality of life. Licensed medicines are mostly for oral administration and are limited by the difficulty in crossing the blood–brain barrier (BBB). Here in, the nasal route has been...
保存先:
| 出版年: | Int J Nanomedicine |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8256381/ https://ncbi.nlm.nih.gov/pubmed/34234432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S305851 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|